Showing results (1671-1680 of 1,689) with videos related to
Sort By:
Pageof 169
Plos Pathogens|August 29, 2018
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7Sakaorat Lertjuthaporn, Claudia Cicala, Donald Van Ryk, et al.JCI Insight|February 7, 2023
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapyJoseph H Azar, John P Evans, Madison H Sikorski, et al.Biorxiv : the Preprint Server for Biology|February 3, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Human Molecular Genetics|May 6, 2015
Identification of a novel FGFRL1 MicroRNA target site polymorphism for bone mineral density in meta-analyses of genome-wide association studiesTianhua Niu, Ning Liu, Ming Zhao, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 11, 2015
Identification of IDUA and WNT16 Phosphorylation-Related Non-Synonymous Polymorphisms for Bone Mineral Density in Meta-Analyses of Genome-Wide Association StudiesTianhua Niu, Ning Liu, Xun Yu, et al.Vaccine|April 20, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trialJing Pu, Qin Yu, Zhifang Yin, et al.Annals of Translational Medicine|November 9, 2019
Evaluation of manual and electronic healthcare-associated infections surveillance: a multi-center study with 21 tertiary general hospitals in ChinaWen-Sen Chen, Wei-Hong Zhang, Zhan-Jie Li, et al.Experimental & Molecular Medicine|July 5, 2019
Author Correction: The wide utility of rabbits as models of human diseasesPedro J Esteves, Joana Abrantes, Hanna-Mari Baldauf, et al.Experimental & Molecular Medicine|May 24, 2018
The wide utility of rabbits as models of human diseasesPedro J Esteves, Joana Abrantes, Hanna-Mari Baldauf, et al.Emerging Microbes & Infections|April 7, 2025
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trialsZoe Moodie, Shuying Sue Li, Elena E Giorgi, et al.Pageof 169